FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385837498> ?p ?o ?g. }

• W4385837498 abstract "During the COVID-19 pandemic, telemedicine has been recognised as a powerful modality to shorten the length of hospital stay and to free up beds for the sicker patients. Lombardy, and in particular the areas of Bergamo, Brescia, and Milan, was one of the regions in Europe most hit by the COVID-19 pandemic. The primary aim of the MIRATO project was to compare the incidence of severe events (hospital readmissions and mortality) in the first three months after discharge between COVID-19 patients followed by a Home-Based Teleassistance and Teleconsultation (HBTT group) program and those discharged home without Telemedicine support (non-HBTT group).The study was designed as a matched case-control study. The non-HBTT patients were matched with the HBTT patients for sex, age, presence of COVID-19 pneumonia and number of comorbidities. After discharge, the HBTT group underwent a telecare nursing and specialist teleconsultation program at home for three months, including monitoring of vital signs and symptoms. Further, in this group we analysed clinical data, patients' satisfaction with the program, and quality of life.Four hundred twenty-two patients per group were identified for comparison. The median age in both groups was 70 ± 11 years (62% males). One or more comorbidities were present in 86% of the HBTT patients and 89% in the non-HBTT group (p = ns). The total number of severe events was 17 (14 hospitalizations and 3 deaths) in the HBTT group and 40 (26 hospitalizations and 16 deaths) in the non-HBTT group (p = 0.0007). The risk of hospital readmission or death after hospital discharge was significantly lower in HBTT patients (Log-rank Test p = 0.0002). In the HBTT group, during the 3-month follow-up, 5,355 teleassistance contacts (13 ± 4 per patient) were performed. The number of patients with one or more symptoms declined significantly: from 338 (78%) to 183 (45%) (p < 0.00001). Both the physical (ΔPCS12: 5.9 ± 11.4) component and the mental (ΔMCS12: 4.4 ± 12.7) component of SF-12 improved significantly (p < 0.0001). Patient satisfaction with the program was very high in all participants.Compared to usual care, an HBTT program can reduce severe events (hospital admissions/mortality) at 3-months from discharge and improve symptoms and quality of life.www.ClinicalTrials.gov, NCT04898179." @default.
• W4385837498 created "2023-08-16" @default.
• W4385837498 creator A5009412180 @default.
• W4385837498 creator A5012163568 @default.
• W4385837498 creator A5013296571 @default.
• W4385837498 creator A5015206826 @default.
• W4385837498 creator A5027726576 @default.
• W4385837498 creator A5032455835 @default.
• W4385837498 creator A5032473580 @default.
• W4385837498 creator A5033221712 @default.
• W4385837498 creator A5039625868 @default.
• W4385837498 creator A5042892367 @default.
• W4385837498 creator A5051380716 @default.
• W4385837498 creator A5070659661 @default.
• W4385837498 creator A5076108156 @default.
• W4385837498 creator A5083460319 @default.
• W4385837498 creator A5088322292 @default.
• W4385837498 creator A5090130707 @default.
• W4385837498 date "2023-08-14" @default.
• W4385837498 modified "2023-10-18" @default.
• W4385837498 title "COVID-19 teleassistance and teleconsultation: a matched case-control study (MIRATO project, Lombardy, Italy)" @default.
• W4385837498 cites W2135060109 @default.
• W4385837498 cites W2143650317 @default.
• W4385837498 cites W2160679825 @default.
• W4385837498 cites W2620092441 @default.
• W4385837498 cites W2981991108 @default.
• W4385837498 cites W3014294089 @default.
• W4385837498 cites W3016535995 @default.
• W4385837498 cites W3022572398 @default.
• W4385837498 cites W3035239279 @default.
• W4385837498 cites W3040230595 @default.
• W4385837498 cites W3107152734 @default.
• W4385837498 cites W3107476024 @default.
• W4385837498 cites W3113271342 @default.
• W4385837498 cites W3120387768 @default.
• W4385837498 cites W3120581533 @default.
• W4385837498 cites W3129076505 @default.
• W4385837498 cites W3135919185 @default.
• W4385837498 cites W3151046065 @default.
• W4385837498 cites W3173289341 @default.
• W4385837498 cites W3193553783 @default.
• W4385837498 cites W3201183353 @default.
• W4385837498 cites W3209950166 @default.
• W4385837498 cites W4281476340 @default.
• W4385837498 cites W4281705638 @default.
• W4385837498 cites W4285288214 @default.
• W4385837498 cites W4288684979 @default.
• W4385837498 cites W4289456206 @default.
• W4385837498 cites W4290803968 @default.
• W4385837498 cites W4307033498 @default.
• W4385837498 cites W4313641178 @default.
• W4385837498 cites W4361000292 @default.
• W4385837498 cites W4366529434 @default.
• W4385837498 cites W4366821841 @default.
• W4385837498 cites W4367668792 @default.
• W4385837498 cites W4367668793 @default.
• W4385837498 doi "https://doi.org/10.3389/fcvm.2023.1062232" @default.
• W4385837498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37645519" @default.
• W4385837498 hasPublicationYear "2023" @default.
• W4385837498 type Work @default.
• W4385837498 citedByCount "0" @default.
• W4385837498 crossrefType "journal-article" @default.
• W4385837498 hasAuthorship W4385837498A5009412180 @default.
• W4385837498 hasAuthorship W4385837498A5012163568 @default.
• W4385837498 hasAuthorship W4385837498A5013296571 @default.
• W4385837498 hasAuthorship W4385837498A5015206826 @default.
• W4385837498 hasAuthorship W4385837498A5027726576 @default.
• W4385837498 hasAuthorship W4385837498A5032455835 @default.
• W4385837498 hasAuthorship W4385837498A5032473580 @default.
• W4385837498 hasAuthorship W4385837498A5033221712 @default.
• W4385837498 hasAuthorship W4385837498A5039625868 @default.
• W4385837498 hasAuthorship W4385837498A5042892367 @default.
• W4385837498 hasAuthorship W4385837498A5051380716 @default.
• W4385837498 hasAuthorship W4385837498A5070659661 @default.
• W4385837498 hasAuthorship W4385837498A5076108156 @default.
• W4385837498 hasAuthorship W4385837498A5083460319 @default.
• W4385837498 hasAuthorship W4385837498A5088322292 @default.
• W4385837498 hasAuthorship W4385837498A5090130707 @default.
• W4385837498 hasBestOaLocation W43858374981 @default.
• W4385837498 hasConcept C120665830 @default.
• W4385837498 hasConcept C121332964 @default.
• W4385837498 hasConcept C126322002 @default.
• W4385837498 hasConcept C160735492 @default.
• W4385837498 hasConcept C162324750 @default.
• W4385837498 hasConcept C187212893 @default.
• W4385837498 hasConcept C194828623 @default.
• W4385837498 hasConcept C2777914695 @default.
• W4385837498 hasConcept C2779134260 @default.
• W4385837498 hasConcept C2779891985 @default.
• W4385837498 hasConcept C2780519836 @default.
• W4385837498 hasConcept C2781050511 @default.
• W4385837498 hasConcept C3008058167 @default.
• W4385837498 hasConcept C50522688 @default.
• W4385837498 hasConcept C524204448 @default.
• W4385837498 hasConcept C61511704 @default.
• W4385837498 hasConcept C71924100 @default.
• W4385837498 hasConcept C89623803 @default.
• W4385837498 hasConceptScore W4385837498C120665830 @default.
• W4385837498 hasConceptScore W4385837498C121332964 @default.
• W4385837498 hasConceptScore W4385837498C126322002 @default.

• next